Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 5/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 4/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409946 | 0.87 | EGLN1 (0.53) | KMT2ATSHRHMGCRCHRM1TBXA2R | |
| SCHEMBL11253721 | 0.87 | ALDH1A1 (0.35) | KMT2AALDH1A1HSD11B1 | |
| SCHEMBL3628615 | 0.87 | ALDH1A1 (0.59) | KMT2AALDH1A1HSD11B1CHRM1 | |
| SCHEMBL5021516 | 0.86 | FAAH (0.40) | KMT2AALDH1A1HSD11B1TSHRFAAH | |
| SCHEMBL16640759 | 0.86 | FAAH (0.46) | KMT2AALDH1A1HSD11B1TSHRFAAH | |
| SCHEMBL7771599 | 0.85 | KMT2A (0.32) | KMT2AMEN1RCE1 | |
| SCHEMBL866506 | 0.85 | KMT2A (0.34) | KMT2AALDH1A1FAAHCYP2C19MEN1 | |
| SCHEMBL903352 | 0.83 | — | — | |
| SCHEMBL330284 | 0.83 | — | — | |
| SCHEMBL12247043 | 0.83 | FAAH (0.48) | KMT2AALDH1A1TSHRFAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737461-A1 | NOVEL COMPOUND, PRECURSOR COMPOSITION COMPRISING SAME, AND METHOD FOR MANUFACTURING THIN FILM USING SAME | Hansol Chemical Co., Ltd (KR) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025005677-A1 | NOVEL COMPOUND, PRECURSOR COMPOSITION COMPRISING SAME, AND METHOD FOR MANUFACTURING THIN FILM USING SAME | 주식회사 한솔케미칼 | 2025-01-02 | — | — | WO | disclosed |
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-10-24 | — | — | US | disclosed |
| US-20230312635-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230303502-A1 | HETEROARYL AND HETEROCYCLYL COMPOUNDS | SIGILON THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| US-20230287138-A1 | PROTEIN-DRUG CONJUGATES COMPRISING CAMPTOTHECIN ANALOGS AND METHODS OF USE THEREOF | REGNERON PHARMACEUTICALS, INC. (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230242570-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230242570-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230227492-A1 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE USA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-07-20 | — | — | US | disclosed |
| US-20230167152-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-06-01 | — | — | US | disclosed |
| US-5032565-A | Using aldehyde, ketone, alcohol, ether or acid | EUROPEENNE RETRAITEMENT DE CATALYSEURS EURECAT (FR) | 1991-07-16 | — | — | US | disclosed |
| US-4656090-A | WITH UNSATURATED AROMATIC HYDROCARBON DILUENTS | GENERAL ELECTRIC COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| US-4603182-A | STYRENE AS REACTIVE DILUENT WITH A CATALYTIC HARDENER AND PHENOLICACCELERATOR | GENERAL ELECTRIC COMPANY (US) | 1986-07-29 | — | — | US | disclosed |
| US-4530917-A | Using a polysulfide sulfuration agent | EURECAT - SOCIETE EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (FR) | 1985-07-23 | — | — | US | disclosed |
| EP-0032290-B1 | PROCESS FOR THE PREPARATION OF 1,4-DIALKYLBUT-2-ENE-1,4-DIONES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-03-14 | — | — | EP | disclosed |
| US-4340764-A | OXIDIZING 2,5-DIALKYLFURAN | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-07-20 | — | — | US | disclosed |
| EP-0032290-A2 | Process for the preparation of 1,4-dialkylbut-2-ene-1,4-diones | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-07-22 | — | — | EP | disclosed |
| EP-0027685-A2 | Improved process for preparing imidazole and 1,2,4-triazole derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-04-29 | — | — | EP | disclosed |
| US-4237242-A | THERMOSETTING RESINS AS A REPLACEMENT FOR METALLIC SOLDERS | ROHM AND HAAS COMPANY (US) | 1980-12-02 | — | — | US | disclosed |
| US-4131715-A | Use of chelated metal catalysts for acid/epoxy polymer systems | ROHM AND HAAS COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287138-A1 | PROTEIN-DRUG CONJUGATES COMPRISING CAMPTOTHECIN ANALOGS AND METHODS OF USE THEREOF | TGM2, QPCT, TGM3 | KMT2A 1644/4885ALDH1A1 1468/4885HSD11B1 4579/4885 |
| US-20230312635-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | POLRMT, RNGTT, POLM | KMT2A 3890/4885ALDH1A1 3605/4885HSD11B1 2157/4885 |
| US-20230227492-A1 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | SHBG, CYP19A1, GNRHR | KMT2A 2356/4885ALDH1A1 2941/4885HSD11B1 593/4885 |
| US-20230303502-A1 | HETEROARYL AND HETEROCYCLYL COMPOUNDS | CYP3A43, CYP2C9, CYP2C19 | KMT2A 4091/4885ALDH1A1 296/4885HSD11B1 397/4885 |
| US-20230167152-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | POLI, POLL, DNMT3A | KMT2A 569/4885ALDH1A1 835/4885HSD11B1 3070/4885 |
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | SLC10A1, SLC10A2, NOTUM | KMT2A 2951/4885ALDH1A1 1580/4885HSD11B1 216/4885 |
| US-20230242570-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | FBL, POLI, POLL | KMT2A 1147/4885ALDH1A1 1681/4885HSD11B1 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.